JP2022543021A5 - - Google Patents

Info

Publication number
JP2022543021A5
JP2022543021A5 JP2022506342A JP2022506342A JP2022543021A5 JP 2022543021 A5 JP2022543021 A5 JP 2022543021A5 JP 2022506342 A JP2022506342 A JP 2022506342A JP 2022506342 A JP2022506342 A JP 2022506342A JP 2022543021 A5 JP2022543021 A5 JP 2022543021A5
Authority
JP
Japan
Application number
JP2022506342A
Other languages
Japanese (ja)
Other versions
JPWO2020243745A5 (https=
JP2022543021A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/070080 external-priority patent/WO2020243745A1/en
Publication of JP2022543021A publication Critical patent/JP2022543021A/ja
Publication of JPWO2020243745A5 publication Critical patent/JPWO2020243745A5/ja
Publication of JP2022543021A5 publication Critical patent/JP2022543021A5/ja
Priority to JP2025093180A priority Critical patent/JP2025143272A/ja
Pending legal-status Critical Current

Links

JP2022506342A 2019-05-29 2020-05-28 がんを処置する方法及び使用 Pending JP2022543021A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025093180A JP2025143272A (ja) 2019-05-29 2025-06-04 がんを処置する方法及び使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962853842P 2019-05-29 2019-05-29
US62/853,842 2019-05-29
PCT/US2020/070080 WO2020243745A1 (en) 2019-05-29 2020-05-28 Methods and uses for treating cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025093180A Division JP2025143272A (ja) 2019-05-29 2025-06-04 がんを処置する方法及び使用

Publications (3)

Publication Number Publication Date
JP2022543021A JP2022543021A (ja) 2022-10-07
JPWO2020243745A5 JPWO2020243745A5 (https=) 2023-06-06
JP2022543021A5 true JP2022543021A5 (https=) 2023-06-06

Family

ID=73553943

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022506342A Pending JP2022543021A (ja) 2019-05-29 2020-05-28 がんを処置する方法及び使用
JP2025093180A Pending JP2025143272A (ja) 2019-05-29 2025-06-04 がんを処置する方法及び使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025093180A Pending JP2025143272A (ja) 2019-05-29 2025-06-04 がんを処置する方法及び使用

Country Status (11)

Country Link
US (1) US11911374B2 (https=)
EP (1) EP3976036A4 (https=)
JP (2) JP2022543021A (https=)
KR (1) KR20220002745A (https=)
CN (2) CN119326899A (https=)
AU (1) AU2020283913A1 (https=)
BR (1) BR112021026294A2 (https=)
CA (1) CA3141072A1 (https=)
IL (1) IL288591B1 (https=)
MX (1) MX2021014686A (https=)
WO (1) WO2020243745A1 (https=)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170326118A1 (en) * 2001-07-02 2017-11-16 Sinan Tas Drug treatment of tumors wherein hedgehog/smoothened signaling is utilized for inhibition of apoptosis of tumor cells
MY150379A (en) * 2008-02-26 2013-12-31 Takeda Pharmaceutical Fused heterocyclic derivative and use thereof
PL2470173T3 (pl) * 2009-08-25 2016-11-30 Leczenie skojarzone nanocząstkowymi kompozycjami taksanu i inhibitorów hedgehog
WO2011156119A1 (en) 2010-06-07 2011-12-15 Abraxis Bioscience, Llc Combination therapy methods for treating proliferative diseases
JP2012097032A (ja) * 2010-11-02 2012-05-24 Takeda Chem Ind Ltd 併用医薬
WO2014165644A2 (en) * 2013-04-04 2014-10-09 The General Hospital Corporation Combination treatments with sonic hedgehog inhibitors
WO2015073691A1 (en) * 2013-11-14 2015-05-21 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating cancer by activation of bmp signaling
US10329304B2 (en) * 2014-09-12 2019-06-25 Vanderbilt University Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase
WO2016141084A1 (en) * 2015-03-03 2016-09-09 The Board Of Trustees Of The Leland Stanford Junior University Producing mesodermal cell types and methods of using the same
US11026889B2 (en) * 2015-12-09 2021-06-08 Board Of Regents, The University Of Texas System Polymeric drug delivery systems for treatment of disease
CN108853507A (zh) * 2017-05-11 2018-11-23 复旦大学 一种抗肿瘤的增效药物组合物及其制备方法和用途
US20200368246A1 (en) * 2017-11-17 2020-11-26 Jaeyoung Yoon Combination therapy targeting cancer associated with the hedgehog pathway

Similar Documents

Publication Publication Date Title
CL2025004119A1 (es) Resistencia a la soja modificada por ingeniería genética.
BR112021017747A2 (https=)
JP2022543021A5 (https=)
CN305967725S (https=)
CN305531458S (https=)
CN305961631S (https=)
CN305960790S (https=)
CN305958429S (https=)
CN305536848S (https=)
CN305957780S (https=)
CN305956971S (https=)
CN305536815S (https=)
CN305536745S (https=)
CN305536619S (https=)
CN305536462S (https=)
CN305535735S (https=)
CN305534513S (https=)
CN305534479S (https=)
CN305533736S (https=)
CN305532383S (https=)
CN305532147S (https=)
CN305531887S (https=)
CN305954850S (https=)
CN305531714S (https=)
CN305531623S (https=)